Postdoctoral Research Associate, Molecular Pharmacology Lab of Dr. Steven M. Larson, Department of Radiology and Sloan Kettering Institute
The Larson lab is seeking a highly motivated and successful individual with a background in radiochemistry, imaging science, chemical biology, or chemistry to undertake preclinical radiotheranostic development for the systemic treatment of solid tumors with alpha- or beta-emitting unsealed isotopes, guided by PET-based staging and dosimetry. We collaborate closely with the lab of Dr. Nai-kong Cheung to employ bispecific antibodies for anti-tumor/anti-radiohapten in vivo pretargeting. Please see https://www.mskcc.org/research/ski/labs/steven-larson for additional information. This full-time post is funded by the National Institutes of Health, National Cancer Institute.
T he ideal candidate should have:
A Ph.D or M.D., or be near completion of their degree, in a relevant subject area.
Background in radiochemistry, organic chemistry, imaging science, autoradiography/immunohistochemistry, or chemical biology. No previous experience in molecular imaging required.
The desire to be a part of a dynamic translational research team.
Please upload CV, a letter outlining your interest and names/contact information of three references with your application. Please direct any questions to Sarah M. Cheal, PhD, Senior Research Scientist, Larson Lab - Cheals@mskcc.org.
Internal Number: 2020-44741
About Memorial Sloan-Kettering Cancer Center
As one of the world's premier cancer centers, Memorial Sloan-Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and the biomedical research agenda around the world.